You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Liraglutide, Empagliflozin and Linagliptin

Showing 1 - 25 of 819
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 2 Diabetes, Mild Cognitive Impairment Trial in Nanjing (Liraglutide, Empagliflozin, Linagliptin)

Recruiting
  • Type 2 Diabetes Mellitus
  • Mild Cognitive Impairment
  • Nanjing, Jiangsu, China
  • +1 more
Mar 28, 2022

Four Second Line Pharmacological Strategies in Type 2 Diabetes

Active, not recruiting
  • Cardiovascular Events
  • +2 more
  • SGLT2 inhibitor
  • +3 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
Feb 17, 2022

Type II Diabetes in Subjects BMI 27 to 32 Trial in Singapore (Roux-en-Y Gastric Bypass (RYGB), Incretin analogues, Xenical)

Completed
  • Type II Diabetes in Subjects BMI 27 to 32
  • Roux-en-Y Gastric Bypass (RYGB)
  • +4 more
  • Singapore, Singapore
    Khoo Teck Puat Hospital
Jun 22, 2022

Comparison of Type 2 Diabetes Pharmacotherapy Regimens

Recruiting
  • Type 2 Diabetes Mellitus
  • Cardiovascular Diseases
  • Oakland, California
  • +5 more
Oct 18, 2022

Healthy Trial in Qingdao (Test Empagliflozin And Linagliptin Tablets, Reference Empagliflozin And Linagliptin tablets)

Completed
  • Healthy
  • Test Empagliflozin And Linagliptin Tablets
  • Reference Empagliflozin And Linagliptin tablets
  • Qingdao, Shandong, China
    The Affiliated Hospital of Qingdao University Phase I Clinical R
Jul 14, 2023

Diabetes, Kidney Transplant; Complications Trial (Empagliflozin 25 MG, Linagliptin 5 mg Oral Tablet)

Not yet recruiting
  • Diabetes Mellitus
  • Kidney Transplant; Complications
  • Empagliflozin 25 MG
  • Linagliptin 5 mg Oral Tablet
  • (no location specified)
Oct 18, 2023

Kidney Transplant; Complications, Diabetes Trial (Empagliflozin 25 MG, Linagliptin)

Not yet recruiting
  • Kidney Transplant; Complications
  • Diabetes Mellitus
  • (no location specified)
Oct 18, 2023

Polycystic Ovary Syndrome (PCOS) Trial in Alexandria (Empagliflozin 25 mg, Linagliptin 10 mg, Metformin 1500 mg)

Recruiting
  • Polycystic Ovary Syndrome (PCOS)
  • Empagliflozin 25 mg
  • +2 more
  • Alexandria, Egypt
    Alexandria University
Jan 14, 2022

Type2 Diabetes Trial in Amsterdam (EMPA/LINA 10/5 mg QD (n=22), LINA/EMPA 5/10 mg QD (N=22), Gliclazide 30 mg QD/BID (N=22))

Active, not recruiting
  • Type2 Diabetes
  • EMPA/LINA 10/5 mg QD (n=22)
  • +2 more
  • Amsterdam, Noord-Holland, Netherlands
    VU University Medical Center
Jan 13, 2022

Fatty Liver, Nonalcoholic, Diabetes, Type 2 Trial in Alexandria (Metformin)

Active, not recruiting
  • Fatty Liver, Nonalcoholic
  • Diabetes Mellitus, Type 2
  • Alexandria, Egypt
    Alexandria University.
Jan 14, 2022

(PMS) in Korean Patients With Type 2 Diabetes Mellitus

Recruiting
  • Diabetes Mellitus, Type 2
  • Cheonan-si, Cheonan-si, Chungcheongnam-do, Korea, Republic of
  • +2 more
Jul 26, 2022

Cognitive Protective Effect of Newer Antidiabetic Drugs

Recruiting
  • Type 2 Diabetes
  • Alexandria, Egypt
    Alexandria University
Jul 24, 2022

Diabetes, Type 2 Trial in Worldwide (Linagliptin, Empagliflozin, Placebo)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Phoenix, Arizona
  • +82 more
Aug 23, 2022

SGLT-2 and DPP-4 Inhibition, Subclinical Inflammation of

Unknown status
  • Type 2 Diabetes
  • Urinary Tract Infections
  • Empagliflozin / Linagliptin or Dapagliflozin/Saxagliptin Pill
  • Empagliflozin or Dapagliflozin Pill
  • Pisa, Italy
    University of Pisa
Jan 27, 2021

Healthy Trial in Biberach (High dose FDC Empagliflozin/Linagliptin/Metformin XR, fed, 1 tab Empagliflozin +1 tab Linagliptin +2

Completed
Has Results
  • Healthy
  • High dose FDC Empagliflozin/Linagliptin/Metformin XR, fed
  • +3 more
  • Biberach, Germany
    Humanpharmakologisches Zentrum Biberach
Feb 25, 2020

Healthy Trial in Biberach (Empagliflozin/linagliptin/metformin HCl, Empagliflozin, Linagliptin)

Completed
Has Results
  • Healthy
  • Empagliflozin/linagliptin/metformin HCl
  • +3 more
  • Biberach, Germany
    Humanpharmakologisches Zentrum Biberach
Feb 25, 2020

Impaired Glucose Tolerance, Insulin Sensitivity, Glucose Metabolism Disorders Trial in Oslo (Metformin capsule 500 mg,

Recruiting
  • Impaired Glucose Tolerance
  • +2 more
  • Metformin capsule 500 mg, Empagliflozin encapsulated tablet 10 mg, Pioglitazone encapsulated tablet 30 mg, Linagliptin encapsulated tablet 5 mg
  • Oslo, Norway
    Oslo University Hospital, Aker Hospital
Apr 5, 2021

Healthy Trial in Biberach (Empagliflozin, Metformin HCl, Linagliptin (fixed dose combination), Empagliflozin, Linagliptin)

Completed
Has Results
  • Healthy
  • Empagliflozin, Metformin HCl, Linagliptin (fixed dose combination)
  • +3 more
  • Biberach, Germany
    Humanpharmakologisches Zentrum Biberach
Feb 6, 2020

Second Line Therapy Medications in Diabetes

Recruiting
  • Diabetes Mellitus, Type 2
  • Wilmington, Delaware
  • +4 more
Dec 22, 2021

Type 2 Diabetes Trial in Toronto (Empagliflozin 25 MG + Liraglutide 1.8 MG, Liraglutide 1.8 MG + Empagliflozin 25 MG)

Unknown status
  • Type 2 Diabetes Mellitus
  • Empagliflozin 25 MG + Liraglutide 1.8 MG
  • Liraglutide 1.8 MG + Empagliflozin 25 MG
  • Toronto, Ontario, Canada
    Renal Physiology Laboratory
Sep 1, 2020

Type 2 Diabetes Trial in Hellerup (LY2403021, LY2403021 , Standardised liquid meal)

Completed
  • Type 2 Diabetes
  • Hellerup, Denmark
    Center for Diabetes Research, Gentofte Hospital, Copenhagen Univ
Apr 6, 2020

Prediabetic State, Insulin Resistance Trial in León (Linagliptin + metformin and Empagliflozin + metformin, Metformin)

Unknown status
  • Prediabetic State
  • Insulin Resistance
  • Linagliptin + metformin and Empagliflozin + metformin
  • Metformin
  • León, Guanajuato, Mexico
    Universidad de Guanajuato
Oct 17, 2019

Diabetes Type 2 Trial in Erlangen (Empagliflozin and Linagliptin, Metformin and Insulin sc)

Completed
  • Diabetes Mellitus Type 2
  • Empagliflozin and Linagliptin
  • Metformin and Insulin sc
  • Erlangen, Bavaria, Germany
    Clinical Research Center, Dept of Nephrology and Hypertenison, U
Jul 26, 2019

Diabetes Type 2 With Proteinuria, Diabetes, Type 2, Diabetes Trial (drug, device, diagnostic test, behavioral)

Not yet recruiting
  • Diabetes Mellitus Type 2 With Proteinuria
  • +12 more
  • Empagliflozin 10 MG
  • +6 more
  • (no location specified)
Oct 17, 2023

Cancer Trial (Empagliflozin 10 MG)

Not yet recruiting
  • Cancer
  • Empagliflozin 10 MG
  • (no location specified)
Oct 22, 2023